AnHeart Therapeutics Funding: $100M Raised, Series A (2019)
AnHeart Therapeutics is based in Hangzhou, China. It has raised $100M in total funding. Latest round: Series A.
AnHeart Therapeutics funding overview
AnHeart Therapeutics is based in Hangzhou, China. AnHeart Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in May 2019. The round record for AnHeart Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Decheng Capital, China Merchants Capital, Cenova Ventures. 3 distinct backers are named across the disclosed rounds.
AnHeart Therapeutics at a glance
Total raised
$100M
Latest round
Series A
Latest round date
May 2019
Headquarters
Hangzhou, China
Notable investors
Decheng Capital, China Merchants Capital, Cenova Ventures
Frequently asked about AnHeart Therapeutics funding
How much has AnHeart Therapeutics raised?
AnHeart Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in AnHeart Therapeutics?
Decheng Capital, China Merchants Capital, Cenova Ventures are named among the investors backing AnHeart Therapeutics.
What was the latest AnHeart Therapeutics funding round?
The most recent disclosed round is a Series A, announced in May 2019.
Where is AnHeart Therapeutics based?
AnHeart Therapeutics is based in Hangzhou, China.
When did AnHeart Therapeutics last raise?
The last disclosed AnHeart Therapeutics round closed in May 2019 at Series A.
We update the AnHeart Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hangzhou and their backers are listed below.
